Pluristem Therapeutics (PSTI) Receives Patent In India For Cell Therapy Production Methods And Compositions
6/16/2014 7:46:33 AM
HAIFA, Israel, June 16, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced it has been granted Patent No. 261087 from India's Office of the Controller General of Patents, Designs & Trade Marks for a patent titled, "Methods for Cell Expansion and Conditioned Media Produced Thereby for Therapy."
Help employers find you! Check out all the jobs and post your resume.
comments powered by